The Modern Approaches in Diagnostic Algorithm of Inflammatory Breast Cancer (The Literature Review)

Inflammatory breast cancer (IBC) is characterized by an aggressive course and high metastatic potential, therefore timely diagnosis affects outcome of the treatment. In the basis of instrumental diagnosis of IBC, standard imaging methods include - mammography and ultrasonography (USG) additional test and modern techniques such as magnetic resonance imaging (MRI) and positron emission tomography/computed tomography (PET/CT) can also be used. Ultrasound is the most highly sensitive technique that allows in terms of any clinic to identify tumor component in suspected IBC in 93% of cases, and determines the possibility for morphological diagnosis. Mammography is the least sensitive method for diagnosing IBC as tumor tissue on the background of tissue edema are difficult to identify (16-80%, depending on the method of mammography), but the method is still required. MRI allows to defect and pinpoint the tumor changes of the breast tissue in the presence of tissue edema in almost all of the patient with IBC. PET/CT during IBC remains the most accurate in staging the tumor process, and the significance of the method includes a visual ization of the tumor in the breast itself. The use of Single-Photon Emission Computed Tomography in the diagnosis of IBC remains to be established. In the diagnostic algorithm of IBC, combination of all the above methods of research should be used, in order to obtain the most complete picture of the disease, which is extremely important in treatment planning.

отечно-инфильтративный рак молочной железы, маммография, ультразвуковое исследование, магнитно-резонансная томография, позитронно-эмиссионная томография, совмещенная с компьютерной томографией, inflammatory breast cancer, mammography, ultrasound, magnetic resonance imaging, positron emission tomography combined with computed tomography

1. Robertson F.M., Bondy М., Yang W. et al. Inflammatory breast cancer: the disease, the biology, the treatment. CA Cancer J. Clin. 2010; 60 (6): 351-375.

2. Dawood S., Merajver S.D., Viens P. et al. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann. Oncol. 2011; 22 (3): 515-523.

3. Sunil R. Lakhani, Ian O. Ellis, Stuart J. Schnittet et al. WHO Classification of Tumors of the Breast 4th Edition. Geneva: World Health Organization, 2012. 67-68.

4. Schairer C., Soliman A.S., Omar S. Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and Tunisia. Cancer Med. 2013; 2 (2): 178-184.

5. Портной С.М. Возможности лечения отечно-инфильтративной формы рака молочной железы: Материалы VIII Российского онкологического конгресса. М., 2004. 31-35.

6. Lee K.W., Chung S.Y., Yang I. et al. Inflammatory breast cancer: imaging findings. Clin. Imaging. 2005; 29: 22-25.

7. Alunni J.P. Imaging inflammatory breast cancer. Diagn. Interv. Imaging. 2012; 93 (2): 95-103.

8. Маммология: Национальное руководство; Под ред. Харченко В.П., Рожкова Н.И. М.: ГЭОТАР-Медиа, 2009. 60 с.

9. Yang W.T., Le-Petross H.T., Macapinlac H. et al. Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings. Breast Cancer Res. Treat. 2008; 109: 417-426.

10. GQnhan-Bilgen I., Ustun E.E., Memis A. Inflammatory breast carcinoma: mammographic, ultrasonographic, clinical, and pathologic findings in 142 cases. Radiology. 2002; 223: 829-838.

11. Tardivon A.A., Viala J., Corvellec R.A. et al. Mammographic patterns of inflammatory breast carcinoma: a retrospective study of 92 cases. Eur. J. Radiol. 1997; 24: 124-130.

12. Kushwaha A.C., Whitman G.J., Stelling C.B. et al. Primary inflammatory carcinoma of the breast: retrospective review of mammographic findings. Am. J. Roentgenol. 2000; 174: 535-538.

13. Клиническая маммология. Тематический сборник. 1-е изд; Под ред. Харченко В.П., Рожкова Н.И. М.: Стром, 2005. 74 с.

14. Le-Petross H., Uppendahl L., Stafford J. et al. Sonographic Features of Inflammatory Breast Cancer. Seminars Roentgenol. 2011; 46 (4): 275-279

15. Vlastos G., Fornage B.D., Mirza N.Q. et al. The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapy. Am. J. Surg. 2000; 179: 446-452.

16. Amant F., Loibl S., Neven P. et al. Breast cancer in pregnancy. Lancet. 2012; 379 (9815): 570-579.

17. Rosen E.L., Blackwell K.L., Baker J.A. et al. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. Am. J. Roentgenol. 2003; 181: 1275-1282.

18. Cheung Y.C., Chen S.C., Su M.Y. et al. Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI. Breast Cancer Res. Treat. 2003; 78: 51-58.

19. Hylton N. MR imaging for assessment of breast cancer response to neoadjuvant chemotherapy. Magn. Reson. Imaging Clin. N. Am. 2006; 14: 383-389.

20. Thukral A., Thomasson D.M., Chow C.K. et al. Inflammatory breast cancer: dynamic contrast-enhanced MR in patients receiving bevacizumab-initial experience. Radiology. 2007; 244: 727-735.

21. Chen J.H., Mehta R.S., Nalcioglu O. et al. Inflammatory breast cancer after neoadjuvant chemotherapy: can magnetic resonance imaging precisely diagnose the final pathological response? Ann. Surg. Oncol. 2008; 15: 3609-3613.

22. Le-Petross C.H., Luc B., Yang W.T. Evolving Role of Imaging Modalities in Inflammatory Breast Cancer. Seminars Oncol. 2008; 35 (1): 51-63.

23. Carbognin G., Calciolari C., Girardi V. et al. Inflammatory breast cancer: MR imaging findings. Radiol. Med. 2010; 115: 70-82.

24. Thomassin-Naggara I., De Bazelaire C., Chopier J. et al. Diffusion-weighted MR imaging of the breast: advantages and pitfalls. Eur. J. Radiol. 2013; 82: 435-443.

25. Alikhassi A., Omranipour R., Alikhassy Z. et al. Congestive Heart Failure versus Inflammatory Carcinoma in Breast. Case Rep. Radiol. 2014: 815-896.

26. Wang L., Wang D., Fei X. et al. A Rim-Enhanced Mass with Central Cystic Changes on MR Imaging: How to Distinguish Breast Cancer from Inflammatory Breast Diseases? PLoS One. 2014; 9 (3): 90355.

27. Le-Petross H.T., Cristofanilli M., Carkaci S. et al. MRI features of inflammatory breast cancer. Am. J. Roentgenol. 2011; 197: 769-776.

28. Yamauchi H., Woodward W.A., Valero V. et al. Inflammatory breast cancer: what we know and what we need to learn. Oncologist. 2012; 17 (7): 891-899.

29. Groheux D., Giacchetti S., Delord M. et al. 18F-FDG PET/CT in staging patients with locally advanced or inflammatory breast cancer: comparison to conventional staging. J. Nucl. Med. 2013; 54 (1): 5-11.

30. Walker G.V., Niikura N., Yang W. et al. Pretreatment Staging Positron Emission Tomography/Computed Tomography in Patients With Inflammatory Breast Cancer Influences Radiation Treatment Field Designs. Int. J. Radiat. Oncol., Biology, Physics. 2012; 83 (5): 1381-1386.

31. Schelling M., Avril N., Nahrig J. et al. Positron emission tomography using Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J. Clin. Oncol. 2000; 18: 1689-1695.

32. Mankoff D.A., Dunnwald L.K., Gralow J.R. et al. Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy. J. Nucl. Med. 2003; 44: 1806-1814.

33. Berg W.A., Weinberg I.N., Narayanan D. et al. High-resolution fluorodeoxyglucose positron emission tomography with compression (“positron emission mammography”) is highly accurate in depicting primary breast cancer. Breast J. 2006; 12: 309-323.

34. Carkaci S., Macapinlac H.A., Cristofanilli M. et al. Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data. J. Nucl. Med. 2010; 50: 231-238.

35. Shigematsu H., Kadoya T., Masumoto N. et al. Role of FDG-PET/CT in Prediction of Underestimation of Invasive Breast Cancer in Cases of Ductal Carcinoma In Situ Diagnosed at Needle Biopsy. Clin. Breast Cancer. 2014; 14 (5): 358-364.

36. Ibusuki M., Yamamoto Y., Kawasoe T. et al. Potential advantage of preoperative three-dimensional mapping of sentinel nodes in breast cancer by a hybrid single photon emission CT (SPECT)/CT system. Surg. Oncol. 2010; 19(2): 88-94.

37. Uren R.F., Howman-Giles R., Chung D.K.V. et al. SPECT/CT scans allow precise anatomical location of sentinel lymph nodes in breast cancer and redefine lymphatic drainage from the breast to the axilla. Breast J. 2012; 21 (4): 480-486.